Trial NCT02379585

View at ClinicalTrials.gov 
Org. Study IDs: 1145332

Last trial update was posted on 2018-04-24

MeSH Interventions

Cyclophosphamide Docetaxel Doxorubicin Paclitaxel Pertuzumab Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

HER2-positive Breast Cancer

Stopping Reasons

PI Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID